Spinal stimulation plus gait training: a new hope for leg movement after injury?

NCT ID NCT07375745

Not yet recruiting Disease control Sponsor: Centre for Interdisciplinary Research in Rehabilitation of Greater Montreal Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Aug 04, 2026 · Updated 3 times

Summary

This study tests whether adding a mild electrical stimulation to the spinal cord (tSCS) during walking therapy can improve leg movement in people with recent spinal cord injury (within 6 months). Forty participants will receive either real or sham stimulation during 20 training sessions. The goal is to see if the combination is safe, feasible, and leads to better motor recovery than walking therapy alone.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: transcutaneous spinal cord stimulation (tSCS)
What this could lead to: If it works, this could point toward a way to improve walking recovery early after spinal cord injury, when the nervous system is most adaptable.
What could go wrong: This is a small, early-stage feasibility study (40 people) with no blinding or placebo control. The stimulation may not provide added benefit over standard gait training alone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GAIT DISORDER, SENSORIMOTOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Gait Disorders, Neurologic Mobility Limitation spinal cord injury

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GAIT DISORDER, SENSORIMOTOR GAIT DISORDERS LOCOMOTION SPINAL CORD INJURY SPINAL CORD INJURY SUBACUTE

Contacts and locations

Locations

Institut de réadaptation Gingras-Lindsay-de-Montréal (IRGLM)

Montreal, Quebec, H3S 2J4, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.